TY  - CHAP
M1  - Book, Section
TI  - Epidemiology, Pathophysiology, and Treatment of Hypertension
A1  - Hall, Michael E.
A1  - Hall, John E.
A1  - Whelton,  Paul K.
A2  - Fuster, Valentin
A2  - Narula, Jagat
A2  - Vaishnava, Prashant
A2  - Leon, Martin B.
A2  - Callans, David J.
A2  - Rumsfeld, John S.
A2  - Poppas, Athena
PY  - 2022
T2  - Fuster and Hurst's The Heart, 15e
AB  - Content  UpdatePhase  2  KARDIA-2  TrialThe  KARDIA-2  trial  was  a  global,  multicenter,  phase  2,  randomized,  double-blind,  placebo-controlled  study  designed  to  evaluate  the  safety  and  efficacy  of  zilebesiran  compared  with  placebo  among  patients  with  uncontrolled  hypertension.  Zilebesiran  is  an  investigational,  biannually  dosed,  subcutaneously  injected  RNA  interference  agent  that  blocks  production  of  angiotensinogen.  Read  More  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/09/09
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1207966522
ER  -